FDA details new 'platform technology' process that could accelerate cell and gene therapy approvals
The FDA on Tuesday released a long-awaited draft guidance explaining how companies can win designations for platform technologies, a regulatory step that could speed up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.